Healthcare in Texas

Texas Healthcare Intel

Wednesday, May 13, 2026
2 min read
4 stories

Welcome to your daily briefing on healthcare developments in Texas. Today we're covering 4 key stories including updates on texas healthcare headlines, background & context. Let's dive in.

1

Texas Healthcare Headlines

1 story

1.1

CMS Updates Moratoria Provider Services and Utilization Data Tool.

The Moratoria Provider Services and Utilization Data Tool has been updated to enhance access to provider data.

Why It Matters

This tool is essential for Texas healthcare professionals to track provider services and ensure compliance with regulations.

Sources:Source
Sponsored

Advertise Here

Reach healthcare professionals

Learn More
2

Background & Context

3 stories

2.1

How MIPS cost-category math actually works.

The MIPS cost performance category is calculated retrospectively by CMS using attributed Medicare claims; clinicians cannot directly affect what is attributed. The two attribution methods (TPCC and MSPB) capture different beneficiary cohorts. Practices that try to "manage" cost without understanding which patients are attributed to which clinician typically waste effort.

Why It Matters

Cost is now 30% of the MIPS final score — the largest single category. Misunderstanding attribution is the leading cause of unfavorable payment adjustments in the next cycle.

2.2

Why prior-auth denials cluster around the same five reasons.

Across most payors, the top-five denial reasons account for over 80% of prior-auth rejections: missing clinical documentation, wrong CPT/HCPCS code, service not in benefit plan, step-therapy not completed, and ordering provider not on the patient's plan. The same five repeat across plans because they are the easiest to deny on automation.

Why It Matters

Practices that build a five-line pre-submission checklist around these reasons typically cut prior-auth denials by 40-60% within a quarter. The fix is process, not appeals capacity.

2.3

340B recertification: the most-missed deadline in pharmacy compliance.

Covered entities must annually recertify their 340B eligibility through HRSA. Missing the recertification window pushes the entity to inactive status, which means immediate loss of 340B pricing and potentially diversion violations on previously dispensed drugs. Reinstatement requires a new application.

Why It Matters

The discount value of 340B pricing for a covered entity often exceeds six figures annually. Letting the recertification lapse for paperwork reasons is one of the most expensive administrative errors in the regulation.

Never Miss an Update

Get Texas healthcare intelligence delivered to your inbox every morning.

Subscribe Free

Subscribe Free

Get Texas healthcare intelligence delivered daily.

Subscribe Now

Issue Summary

DateMay 13, 2026
Stories4
Sections2
Read Time2 min
Sponsored

Advertise Here

Reach healthcare professionals

Learn More

Browse Archive

View all past issues

National Partner

Reach Professionals Nationwide

Feature your brand across the U.S., Canada, and select international markets and 10 industry verticals.

Become a National Partner